HospitalsAescia for Hospitals is an investigational Software as a Medical Device under the TGA Class IIa pathway. Not yet available for commercial supply.
ClinicsAescia for Clinics is a workflow and patient-preparation tool. It does not propose clinical decisions and is not a medical device.
Aescia is built by a small team that writes its own pathways and ships its own code. Two products, one engine, one team.
Founder and Chief Executive Officer
A hospital doctor with critical care experience, who trained and practised across rural New South Wales (Wagga Wagga) and Sydney. Authors the clinical pathway engine and leads company strategy.
Read full bioCo-founder and Chief Technology Officer
PhD from Concordia University in building-energy machine learning. Leads security, hosting, artificial intelligence inference, electronic medical record integration and the pathway authoring infrastructure that underpins both products.
Resident Director, Aescia Pty Ltd
Holds the statutory Resident Director role required by the Australian Corporations Act for Aescia Pty Ltd. Not an operational position.
Aescia for Hospitals has been in a live trial at Royal Prince Alfred Hospital since June 2026, with good early results.
Principal Investigator of the SAFE-Discharge trial at Royal Prince Alfred Hospital, sponsored by Sydney Local Health District
BMed MBBS MPhil. Cardiothoracic researcher, The Baird Institute and Royal Prince Alfred Hospital.
Advisers are named as each joins and consents.
For enquiries about advisory roles, use the contact page.
Early-stage buyers underwrite company risk. Below: how Aescia is funded, who answers when something is wrong, and who works on the company.
Want to meet the team?
Request a briefing